|
|
p38mapk cascade
|
GO:0038066 |
4 |
0.291
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.266
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.231
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.214
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.210
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.178
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.175
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.174
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.172
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.171
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.165
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.161
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.158
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.141
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.136
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.130
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.122
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.120
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.119
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.117
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.115
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.114
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.113
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.112
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.110
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.108
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.107
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.107
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.106
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.105
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.104
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.103
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.103
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.103
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.102
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.102
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.101
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.101
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.100
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.100
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.098
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.097
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.094
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.094
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.093
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.090
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.090
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.087
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.086
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.086
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.085
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.085
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.085
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.084
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.084
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.083
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.080
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.080
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.079
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.078
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.078
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.076
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.076
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.076
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.074
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.074
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.073
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.072
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.072
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.071
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.071
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.071
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.071
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.070
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.070
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.070
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.070
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.069
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.069
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.068
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.068
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.066
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.066
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.065
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.064
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.063
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.063
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.062
|
|
|
|
regulation of p38mapk cascade
|
GO:1900744 |
3 |
0.062
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.062
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.062
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.061
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.060
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.060
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.060
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.060
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.060
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.060
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.060
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.059
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.059
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.058
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.058
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.057
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.057
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.056
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.056
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.055
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.055
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.055
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.054
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.054
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.054
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.054
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.054
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.054
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.053
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.052
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.052
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.051
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.051
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.050
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.049
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.049
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.049
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.049
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.048
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.048
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.048
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.048
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.048
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.048
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.047
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.047
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.047
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.047
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.046
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.046
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.045
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.045
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.045
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.045
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.045
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.045
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.044
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.044
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.043
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.043
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.043
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.043
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.043
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.043
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.043
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.042
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.042
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.042
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.042
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.041
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.041
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.041
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.041
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.040
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.040
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.040
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.040
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.040
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.040
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.039
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.039
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.039
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.039
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.039
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.038
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.038
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.038
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.038
|
Mouse |
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.038
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.038
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.038
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.038
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.038
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.038
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.038
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.037
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.037
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.037
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.037
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.036
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.036
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.036
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.036
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.035
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.035
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.035
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.035
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.035
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.035
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.035
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.034
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.034
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.034
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.034
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.034
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.034
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.034
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.034
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.033
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.033
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.033
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.033
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.032
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.032
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.032
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.032
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.032
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.032
|
Mouse |
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.032
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.032
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.032
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.031
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.031
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.031
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.031
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.031
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.031
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.031
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.031
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.030
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.030
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.030
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.030
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.030
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.030
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.030
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.030
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.030
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.030
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.030
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.030
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.030
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.029
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.029
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.029
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.029
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.029
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.029
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.028
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.028
|
|
|
|
male germ line stem cell asymmetric division
|
GO:0048133 |
2 |
0.028
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.028
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.028
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.028
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.028
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.028
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.028
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.028
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.028
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.027
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.027
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.027
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.027
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.027
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.027
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.027
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.027
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.026
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.026
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.026
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.026
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.026
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.026
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.026
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.026
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.026
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.026
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.026
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.025
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.025
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.025
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.025
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.025
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.025
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.025
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.025
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.025
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.025
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.025
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.025
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.025
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.025
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.025
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.025
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.025
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.025
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.025
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.024
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.024
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.024
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.024
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.024
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.024
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.024
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.024
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.024
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.024
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.024
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.024
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.024
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.024
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.024
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.024
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.024
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.024
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.024
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.024
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.024
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.023
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.023
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.023
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.023
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.023
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.023
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.023
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.023
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.023
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.023
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.023
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.023
|
|
|
|
nucleus localization
|
GO:0051647 |
20 |
0.023
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.023
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.023
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.023
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.023
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.023
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.023
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.022
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.022
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.022
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.022
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.022
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.022
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.022
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.022
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.022
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.022
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.022
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.022
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.022
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.022
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.022
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.022
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.022
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.022
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.022
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.022
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.022
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.021
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.021
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.021
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.021
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.021
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.021
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.021
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.021
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.021
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.021
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.021
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.021
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.021
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.021
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.021
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.021
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.021
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.021
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.021
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.021
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.021
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.021
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.021
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.021
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.021
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.021
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.021
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.021
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.021
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.020
|
|
|
|
regulation of mesenchymal cell proliferation involved in lung development
|
GO:2000790 |
2 |
0.020
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.020
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.020
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.020
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.020
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.020
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.020
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.020
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.020
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.020
|
|
|
|
negative regulation of protein kinase activity by regulation of protein phosphorylation
|
GO:0044387 |
2 |
0.020
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.019
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.019
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.019
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.019
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.019
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.019
|
|
|
|
regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072364 |
7 |
0.019
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.019
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.019
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.019
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.019
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.019
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.019
|
|
|
|
sensory perception of umami taste
|
GO:0050917 |
4 |
0.019
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.019
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.019
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.019
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.019
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.019
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.019
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.019
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.019
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.019
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.018
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.018
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.018
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.018
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.018
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.018
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.018
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.018
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.018
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.018
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.018
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.018
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.018
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.018
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.018
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.018
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.018
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.018
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.018
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.018
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.018
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.018
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.018
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.018
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.018
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.018
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.018
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.018
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.018
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.018
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.018
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.017
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.017
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.017
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.017
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.017
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.017
|
|
|
|
regulation of activin receptor signaling pathway
|
GO:0032925 |
10 |
0.017
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.017
|
|
|
|
regulation of protein acetylation
|
GO:1901983 |
22 |
0.017
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.017
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.017
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.017
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.017
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.017
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.017
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.017
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.017
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.017
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.017
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.017
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.017
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.017
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.017
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
40 |
0.017
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.017
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.017
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.017
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.017
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.017
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.017
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.016
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.016
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.016
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.016
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.016
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.016
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.016
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.016
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.016
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.016
|
|
